Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NexgenRx Inc V.NXG

Alternate Symbol(s):  NEGXF

Financial Services Insurance Brokers
NexgenRx Inc. is a Canada-based third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The Company offers plan sponsors, administration and health benefit technology applications... see more

Bullboard (TSXV:NXG)

View:
1 2 Next
Post by mba123ccuon Nov 29, 2022 7:56pm

Revenue Growth

NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow Lots of positives here, with the move to a modern more efficient office and smaller ...more  
259
Post by Amamealon Aug 24, 2022 7:08pm

High quality long position

The business is growing. GTAL.
88
Post by AuAgLi8on Jan 20, 2022 1:26pm

Dividend

-Hopefully the first of many , conservative but that is good. -Management continues to methodically build this company. -This company is undervalued at these prices . -DYOc
190
Post by AuAgLi8on Oct 09, 2021 7:03am

Interesting market action

- Volume multifold from benchmark on October 8/2021. -Looks like someone is intrigued with NexgenRX. -This under the radar company deserves watching. -Tightly held by long term investors . -Strong ...more  
219
Comment by jcorobowon Jul 08, 2021 2:47pm

RE:CFO buys 40,500 shares at $.34

Insiders are scooping up shares big time at $.34
101
Discussion
Post by jcorobowon May 27, 2021 9:26am

A few points from Q1 release

- Revenue up YoY - No CEWS - Administration Fees revenue up YoY - EBITDA margin increased from 20% to 25% YoY Great cost cutting measures this Q. Just need transaction revenue to increase once people ...more  
159
Post by AuAgLi8on May 27, 2021 6:51am

More good results

-"The RETIREMENT of ALL outstanding DEBT." --Growth in EBITDA and Net Profit. -Draw Your Own conclusions.
120
Comment by jcorobowon May 03, 2021 3:47pm

RE:I wish it would trade

I wouldn't worry too much about the volume - the way I see it the only way im giving up these shares is a takeover.
65
Discussion
Post by PappyGalloon Apr 26, 2021 8:25pm

I wish it would trade

NexgenRx is stuck with a bid of 37 cents and ask of 54 cents.   It has been a few days where no one has bought or sold any shares. I find it a bit unusual.   I am holding out for ...more  
147
Discussion
Post by jcorobowon Apr 22, 2021 12:20pm

M&A in the industry

People Corporation Significantly Expands its National Advisor Network and Broadens its Client and Advisor Solution Offering Through the Acquisition of Benefits by Design https://www.peoplecorporation ...more  
84
Post by jcorobowon Apr 19, 2021 12:34pm

Big moves today

up 76% today, feels like there's a new buyer out there
83
Post by Gravitymatterson Apr 02, 2021 5:13am

Wonderful Results

- Showing stability. - Gigantic future potential for high margin growth , meanwhile fine tuning and turning a profit. -Uniquely positioned. -Undervalued. -Increasingly becoming a Jewel coveted by ...more  
257
Comment by jcorobowon Apr 01, 2021 9:46am

RE:NXG

Great results for the year. This years revenue was also impacted by reduction in claims due to people staying at home and not going to dentists, chiroporactors etc. Annual revenue (not including CEWS) ...more  
119
Discussion
Post by AuAgLi8on Apr 01, 2021 6:32am

NXG

-EBITDA UP. -SALES UP in spite of COVID. -NET PROFIT UP. -COSTS DOWN. -Unique positioning in the market place. -Adaptable. -Superior Software and Functionality. -Undervalued. -What are Your Thoughts ...more  
227
Discussion
1 2 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities